50 Hoops tips off the fight against prostate cancer
How 50 Hoops uses an annual basketball tournament to educate underserved communities about prostate cancer screenings and treatment options. Ed Sanders knew he needed to have his prostate-specific antigen (PSA) levels checked. After multiple nudges and reminders from...
read more
Our Favorite Patient Resources
Some of Isoray’s favorite patient advocacy groups and organizations who educate and support the men and families affected by prostate cancer.
read moreThe importance of prostate cancer support networks
Prostate cancer survivor John Aguzino and his daughter Celeste discuss his prostate cancer treatment journey and the importance of prostate cancer support networks. The importance of support networks for men undergoing treatment for prostate cancer can not be...
read more
Pioneer in Salvage Brachytherapy Shares Insight on Best Practices for Treatment
Dr. Edward Soffen, the physician who recently unveiled ground-breaking research demonstrating the effectiveness of brachytherapy in salvage procedures, shared his thoughts on how best to ensure a successful execution of this highly effective treatment in the fight...
read more
Prostate cancer survivor Dave Ricordati: “Do your own homework.”
During Dave’s initial diagnosis for prostate cancer, his primary care physician and his urologist did not steer him toward brachytherapy. “Assuming you are not going to hear all of your options from your physician, and you are kind of on your own, then I always...
read moreProstate Cancer Survivor, Dave Ricordati, Tells His Story
Like many men who have been diagnosed with prostate cancer, Dave knew very little about the prostate, what his diagnosis would entail, and most importantly, his options for treatment.
Due to his experience, with his treatment behind him and PSA levels normalized, he takes every chance he can get to talk to men who have been newly diagnosed with prostate cancer. “I think that is what I can do best for men: let them know my experience,” says Dave. “Be informed, have the facts, and then they can make their own decision.”
read moreHard Evidence: The Clinical Case for Brachytherapy Treating Intermediate- and High-Risk Prostate Cancer
Dr. Bradley Prestidge is the Medical Director of the Bon Secours Cancer Institute at DePaul Medical Center in Norfolk, Virginia. He has a deep and extensive background with brachytherapy, using the treatment to overcome prostate, breast, gynecologic and head and neck...
read more
WKYT: “Lexington cancer doctor saving women’s lives”
Cesium-131 Brachytherapy pioneer, Dr. Jonathan Feddock was recently featured by WKYT, leading the fight against recurrent gynecologic cancer. “It's estimated every six minutes in this country, a doctor diagnoses a woman with gynecologic cancer or cancer of the...
read moreIsoRay Announces Appointment of Mark Austin as Controller, Principal Accounting and Financial Officer
RICHLAND, Wash., July 7, 2017 -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck and gynecological cancers, today announced...
read more
IsoRay CEO Thomas LaVoy Talks The Future Of Cesium-131 Brachytherapy With The Wall Street Transcript
The Wall Street Transcipt recently sat with IsoRay CEO Thomas LaVoy to gain insights into the company's isotope used in brachytherapy, the patient experience, and the future of Cesium-131 in additional markets. IsoRay, Inc. (NYSEMKT: ISR) THOMAS LAVOY is Chairman of...
read more